N-(6,7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N-(6,7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

● In Stock

Catalogue No.:VE0022768
CAS No.:N/A
Mol. Formula:C17H15N3O4
Mol. Weight:325.32 g/mol

Additional information on N-(6 | 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

Parent drug

Cabozantinib

IUPAC Name

N-(6, 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

OC1=CC=C(N(C2=CC=NC3=C2C=C(OC)C(OC)=C3)N=O)C=C1

InChI

InChI=1S/C17H15N3O4/c1-23-16-9-13-14(10-17(16)24-2)18-8-7-15(13)20(19-22)11-3-5-12(21)6-4-11/h3-10, 21H, 1-2H3

Description

The compound N-(6 | 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Cabozantinib. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url